Efficacy and Safety of Activated Recombinant Human Factor VII in Treatment of Bleeding in Patients Following Allogeneic Stem Cell Transplantation

Clinical trial NCT01562158 · COMPLETED

Trial details

NCT number: NCT01562158
Sponsor: Novo Nordisk A/S
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Acquired Bleeding Disorder Bleeding During/Following Surgery

Start date: 2001-04-01
Primary completion: 2003-10-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.